Although we found KO of STK11 sensitized to IFN-γ, STK11 mutation is associated with resistance to immunotherapy in lung adenocarcinoma,67 implying potential tissue-type or genotype-specific differences, and highlighting that our reductionist in vitro approach does not consider the potential effects on immune cells. Here, STK11 is linked to lung adenocarcinoma.